Physician

Alan Rudick, D.O.

According to 2025 Medicare claims, Alan Rudick, D.O. (NPI: 1508866971) practices pulmonary disease in the Canton-Massillon, OH market, with the plurality of this provider's patient population coming from Stark, OH. This provider's primary affiliated billing organization is THE CLEVELAND CLINIC FOUNDATION (NPI: 1679525919; TIN: 340714585) and primary practice location at 44685-8372. Rudick is affiliated with the Cleveland Clinic Medicare ACO, LLC (ACO ID: A2729), participating under the MSSP model.

Rudick's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 371 traditional Medicare patients, billed 997 HCPCS/CPT codes, and received $60,004 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,521 prescription claims across 256 beneficiaries totaling $637,170 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 1,498 claims. Open Payments data shows 2 records totaling $122. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $181,825 to $60,004. In contrast, Part D prescription costs have risen steadily, from $172,132 to $637,170. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $57,004 and ending at $80,246.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	375	2,213	$181,825
2016	418	2,234	$167,682
2017	440	1,516	$110,327
2018	344	928	$81,815
2019	346	915	$92,381
2020	330	1,239	$86,471
2021	349	770	$72,357
2022	321	779	$67,046
2023	350	808	$68,735
2024	371	997	$60,004

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	168	953	$172,132
2016	190	1,373	$390,781
2017	192	1,397	$660,203
2018	136	970	$352,307
2019	158	1,130	$406,844
2020	160	1,094	$576,162
2021	188	1,313	$669,332
2022	244	1,914	$813,998
2023	278	1,938	$1,035,599
2024	256	1,521	$637,170

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	161	624	$46,466
2016	220	810	$59,181
2017	370	1,314	$70,079
2018	296	1,128	$45,872
2019	223	876	$29,602
2020	280	940	$38,603
2021	277	820	$34,052
2022	287	935	$46,527
2023	480	1,290	$71,403
2024	552	1,498	$73,827

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	103	153	$84
94726	Test to determine lung volumes using sensors	64	64	$22
94729	Test to examine how well the lungs exchange gases	89	90	$21
94060	Test to measure expiratory airflow and volume changes before and after medication administration	80	81	$16
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	78	108	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	92	4,318	$90,398
Dupixent Pen	Dupilumab	14	392	$50,287
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	61	3,060	$45,501
Spiriva Respimat	Tiotropium Bromide	47	2,190	$37,646
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	53	2,310	$36,012

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	23	195	$14,013
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	13	$13,086
E0601	Continuous positive airway pressure (cpap) device	Y	35	192	$6,864
A7030	Full face mask used with positive airway pressure device, each	N	39	77	$6,240
A7031	Face mask interface, replacement for full face mask, each	N	34	74	$5,604

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$122	HARMONY BIOSCIENCES LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alan Rudick, D.O.?

Tedicare shows public-source Medicare data for Alan Rudick, D.O. (NPI 1508866971), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan Rudick, D.O. have ACO affiliation data?

Alan Rudick, D.O. is shown with ACO affiliation data for Cleveland Clinic Medicare ACO, LLC (MSSP, ACO ID A2729).

What billing organization is linked to Alan Rudick, D.O.?

Alan Rudick, D.O. is linked to THE CLEVELAND CLINIC FOUNDATION (billing NPI 1679525919) in the available physician profile data.

Does Alan Rudick, D.O. have Open Payments data?

Alan Rudick, D.O. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.